This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Building Medical Affairs Capabilities To Ensure Organizational Success Across Key Operational Areas

CHAPEL HILL, N.C., May 24, 2013 /PRNewswire/ -- Regulatory and marketplace changes have pushed Medical Affairs to the forefront of many organizations' priority list.

Forward-thinking companies across the biopharmaceutical and medical device sectors understand a strong Medical Affairs function is essential to meeting current challenges in clinical development, market education, and regulatory compliance. These areas must operate effectively to create a vital bridge between an organization and one of the most critical stakeholders in the healthcare marketplace: physicians.

Appropriate spending and staffing across these activities is one of the challenges facing the Medical Affairs function as it attempts to balance its growing role across the organization.

According to recent research from Best Practices, LLC, the budget allocation for Medical Science Liaisons increased from 11% in 2009 to 18% of total Medical Affairs spend in 2012. Outcomes Research also increased to nearly 10% of budget in 2012, up from 2% in 2009.

" Building Best-in-Class Capabilities in Medical Affairs" is a report that opens a window into these types of trends within the Medical Affairs function. Beyond trends in budget and staffing, the 116-page report provides benchmark metrics and insights that:
  • Illustrate how leading Pharmaceutical and Medical Device companies structure and organize their Medical Affairs functions based on industry and market changes.
  • Identify trends expected to impact the allocation of resources across different Medical Affairs functions.
  • Analyze how regulatory requirements are internalized and managed by Medical Affairs.
  • Describe the success factors and top current challenges regarding Medical Affairs.
  • Identify what percentage of MA budget leading companies allocate for outsourcing spending.
  • Trace how successful Medical Affairs organizations work cross-functionally to enhance effectiveness.

The report is based on the insights of 68 Medical Affairs executives and managers at 50 leading global companies. The benchmark class in this study consists of a Mature Markets and Emerging Markets Segment. Seven deep-dive interviews with industry veterans provided qualitative data.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,951.94 +39.65 0.23%
S&P 500 1,995.83 +15.91 0.80%
NASDAQ 4,766.4410 -24.7110 -0.52%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs